{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:30:46Z","timestamp":1790497846488,"version":"4.1.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160046","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T17:44:18Z","timestamp":1470332658000},"page":"e0160046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":171,"title":["Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies"],"prefix":"10.1371","volume":"11","author":[{"given":"Luis A.","family":"Garc\u00eda Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Mart\u00edn-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"issue":"5\u20136","key":"ref1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"JR Vane","year":"2003","journal-title":"Thromb Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1054-3589(08)60566-9","article-title":"A pharmacological analysis of aspirin","volume":"7","author":"HO Collier","year":"1969","journal-title":"Adv Pharmacol"},{"issue":"3\u20134","key":"ref3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"C Patrono","year":"1980","journal-title":"Thromb Res"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","article-title":"Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy","volume":"72","author":"TD Warner","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"7141","key":"ref5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.316.7141.1337","article-title":"ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","volume":"316","author":"C Baigent","year":"1998","journal-title":"BMJ"},{"issue":"9678","key":"ref6","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"JP Mohr","year":"2001","journal-title":"N Engl J Med"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial","volume":"289","author":"PB Gorelick","year":"2003","journal-title":"Jama"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1001\/jama.2014.15690","article-title":"Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial","volume":"312","author":"Y Ikeda","year":"2014","journal-title":"JAMA"},{"issue":"9250","key":"ref10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project","volume":"357","author":"G de Gaetano","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"AM Algra","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7270","key":"ref12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis","volume":"321","author":"S Derry","year":"2000","journal-title":"Bmj"},{"issue":"22","key":"ref13","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"J He","year":"1998","journal-title":"Jama"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacc.2014.03.049","article-title":"Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis","volume":"64","author":"S Halvorsen","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2 Suppl","key":"ref15","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"PO Vandvik","year":"2012","journal-title":"Chest"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"JF Meschia","year":"2014","journal-title":"Stroke"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cgh.2014.11.007","article-title":"Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants","volume":"13","author":"A Lanas","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7015-4-22","article-title":"Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications","volume":"4","author":"S Hernandez-Diaz","year":"2006","journal-title":"BMC medicine"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-014-9971-7","article-title":"Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population","volume":"30","author":"MA Thorat","year":"2015","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e98326","DOI":"10.1371\/journal.pone.0098326","article-title":"A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: a case-crossover design","volume":"9","author":"IC Wu","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: Long-term observational follow-up of a randomized trial","volume":"159","author":"NR Cook","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fphar.2010.00126","article-title":"Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes","volume":"1","author":"L Cea Soriano","year":"2010","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6904-1-1","article-title":"Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations","volume":"1","author":"FJ de Abajo","year":"2001","journal-title":"BMC Clinical Pharmacology"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00228-012-1386-3","article-title":"Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: A nested case-control study in a new general practice database","volume":"69","author":"FJ de Abajo","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.110.973008","article-title":"Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications","volume":"123","author":"LA Garcia Rodriguez","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"LA Garcia Rodriguez","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/STROKEAHA.111.619411","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture","volume":"42","author":"DM Hasan","year":"2011","journal-title":"Stroke"},{"issue":"1","key":"ref29","first-page":"70","article-title":"Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention a population-based, nested case-control study","volume":"7","author":"KJ Lin","year":"2014","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"2","key":"ref30","first-page":"137","article-title":"Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding","volume":"5","author":"WJ Blot","year":"2000","journal-title":"Journal of epidemiology and biostatistics"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e15721","DOI":"10.1371\/journal.pone.0015721","article-title":"A prospective study of aspirin use and the risk of gastrointestinal bleeding in men","volume":"5","author":"ES Huang","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.amjmed.2010.12.022","article-title":"Long-term use of aspirin and the risk of gastrointestinal bleeding","volume":"124","author":"ES Huang","year":"2011","journal-title":"American Journal of Medicine"},{"issue":"7\u20138","key":"ref33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00365521.2011.568522","article-title":"Incidence of gastrointestinal bleeding in patients with cardiovascular disease: Buffered aspirin versus enteric-coated aspirin","volume":"46","author":"Y Hirata","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes","volume":"307","author":"G De Berardis","year":"2012","journal-title":"JAMA"},{"issue":"7571","key":"ref35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based case-control study","volume":"333","author":"J Hallas","year":"2006","journal-title":"British Medical Journal"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2036.2006.02759.x","article-title":"Upper gastrointestinal bleeding associated with antiplatelet drugs","volume":"23","author":"L Ibanez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/clpt.1993.55","article-title":"Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding","volume":"53","author":"DW Kaufman","year":"1993","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","article-title":"The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption","volume":"94","author":"DW Kaufman","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"9039","key":"ref39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(96)01254-8","article-title":"Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product","volume":"348","author":"JP Kelly","year":"1996","journal-title":"Lancet"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding","volume":"343","author":"A Lanas","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"A Lanas","year":"2006","journal-title":"Gut"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00228-006-0171-6","article-title":"Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan","volume":"62","author":"C Sakamoto","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1365-2036.1999.00631.x","article-title":"Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users","volume":"13","author":"S Santolaria","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2036.2002.01197.x","article-title":"Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding","volume":"16","author":"WA Stack","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/ajg.2015.98","article-title":"Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID\/Low-Dose Aspirin Users","volume":"110","author":"C Sostres","year":"2015","journal-title":"American Journal of Gastroenterology"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-8-57","article-title":"Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients\u2014a longitudinal observational study","volume":"8","author":"WY Leung","year":"2009","journal-title":"Cardiovascular Diabetology"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF03327372","article-title":"The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs","volume":"15","author":"A Pilotto","year":"2003","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1572-0241.2000.02248.x","article-title":"Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin","volume":"95","author":"HT Sorensen","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2036.2006.02784.x","article-title":"Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy","volume":"23","author":"AS Taha","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10350-007-9137-8","article-title":"Assessment of the risk factors for colonic diverticular hemorrhage","volume":"51","author":"A Yamada","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1053\/j.gastro.2011.02.004","article-title":"Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding","volume":"140","author":"LL Strate","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/STROKEAHA.114.006476","article-title":"Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: Impact of quality of anticoagulation control","volume":"46","author":"CW Ho","year":"2015","journal-title":"Stroke"},{"issue":"7186","key":"ref53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/bmj.318.7186.759","article-title":"Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study","volume":"318","author":"AG Thrift","year":"1999","journal-title":"BMJ"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00535-009-0074-2","article-title":"Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy","volume":"44","author":"M Nakayama","year":"2009","journal-title":"J Gastroenterol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study","volume":"163","author":"SO Dalton","year":"2003","journal-title":"Arch Intern Med"},{"key":"ref56","unstructured":"Whitlock E, Burda B, Williams S, Guiguis-Blake J, Evans C. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Draft Evidence Summary: Harms of Aspirin Use Draft Evidence Review for Aspirin to Prevent Cardiovascular Disease and Cancer. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-evidence-summary-harms-of-aspirin-use\/aspirin-to-prevent-cardiovascular-disease-and-cancer\" xlink:type=\"simple\">http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-evidence-summary-harms-of-aspirin-use\/aspirin-to-prevent-cardiovascular-disease-and-cancer<\/ext-link>. Accessed 23 September 2015."},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3748\/wjg.v19.i11.1673","article-title":"Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy","volume":"19","author":"J Iwamoto","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00535-009-0040-z","article-title":"Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy","volume":"44","author":"H Endo","year":"2009","journal-title":"J Gastroenterol"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/00365520903453182","article-title":"Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage","volume":"45","author":"A Shiotani","year":"2010","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/pds.3391","article-title":"Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network","volume":"22","author":"D Gaist","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","DOI":"10.1160\/TH15-04-0316","article-title":"Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark","volume":"114","author":"A Pottegard","year":"2015","journal-title":"Thromb Haemost"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","article-title":"Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study","volume":"6","author":"CE Lovelock","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"J Cuzick","year":"2015","journal-title":"Ann Oncol"},{"key":"ref64","unstructured":"Helicobacter Eradication Aspirin Trial (HEAT). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01506986\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01506986<\/ext-link>. Accessed 23 July 2015."},{"issue":"17","key":"ref65","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3748\/wjg.v21.i17.5382","article-title":"Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries","volume":"21","author":"C Mo","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"A Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref67","unstructured":"Bayer HealthCare. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.arrive-study.com\/en\/study.cfm\" xlink:type=\"simple\">http:\/\/www.arrive-study.com\/en\/study.cfm<\/ext-link>. Accessed 23 July 2015."},{"key":"ref68","unstructured":"National institute on aging. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nia.nih.gov\/alzheimers\/clinical-trials\/aspirin-reducing-events-elderly-aspree\" xlink:type=\"simple\">https:\/\/www.nia.nih.gov\/alzheimers\/clinical-trials\/aspirin-reducing-events-elderly-aspree<\/ext-link>. Accessed 23 July 2015."},{"key":"ref69","unstructured":"ASCEND. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ctsu.ox.ac.uk\/ascend\/\" xlink:type=\"simple\">https:\/\/www.ctsu.ox.ac.uk\/ascend\/<\/ext-link>. Accessed 23 July 2015."},{"key":"ref70","article-title":"Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice","author":"A Battistoni","year":"2015","journal-title":"Clin Cardiol"},{"key":"ref71","article-title":"Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement","author":"K Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"issue":"8","key":"ref72","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrcardio.2014.88","article-title":"Prevention: Aspirin in primary prevention needs individual judgements","volume":"11","author":"CH Hennekens","year":"2014","journal-title":"Nat Rev Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T03:05:52Z","timestamp":1540350352000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160046"}},"subtitle":[],"editor":[{"given":"Tobias","family":"Eckle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}